Skip to main content
Log in

Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Taksin AL, Legrand O, Raffoux E, de Revel T, Thomas X, Contentin N et al. High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group. Leukemia 2007; 21: 66–71.

    Article  CAS  Google Scholar 

  2. Mrozek K, Bloomfield CD . Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia. Hematology 2006 Education program book. American Society of Hematology: Washington, DC, 2006, 169–177.

    Google Scholar 

  3. Garrido SM, Bryant E, Appelbaum FR . Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities. Leuk Res 2000; 24: 481–486.

    Article  CAS  Google Scholar 

  4. Larson RA, Sivers EL, Stadtmauer EA, Lowenberg B, Estey EH, Dombret H et al. Final report on the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33 positive acute myeloid leukemia in first recurrence. Cancer 2001; 104: 1442–1452.

    Article  Google Scholar 

  5. Muñoz L, Nomdedéu JF, Villamor N, Guardia R, Colomer D, Ribera JM et al. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Leukemia 2003; 17: 76–82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Tamai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamai, H., Shioi, Y., Yamaguchi, H. et al. Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion. Leukemia 22, 1273–1274 (2008). https://doi.org/10.1038/sj.leu.2405029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405029

  • Springer Nature Limited

This article is cited by

Navigation